Evidence map›Paper›PMID 35022281›Full record

ArticleSaudi medical journal2022

The antimicrobial activity of ceftobiprole against Methicillin-resistant

Lamees A Altamimi, Leen A Altamimi, Ali M Somily

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Saudi medical journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Lamees A AltamimiFrom the College of Medicine (Lamees Altamimi, Leen Altamimi), and from the Department of Pathology and Laboratory Medicine (Somily), King Saud University, King Saud University Medical City, Riyadh, Kingdom of Saudi Arabia.
Leen A AltamimiFrom the College of Medicine (Lamees Altamimi, Leen Altamimi), and from the Department of Pathology and Laboratory Medicine (Somily), King Saud University, King Saud University Medical City, Riyadh, Kingdom of Saudi Arabia.
Ali M SomilyFrom the College of Medicine (Lamees Altamimi, Leen Altamimi), and from the Department of Pathology and Laboratory Medicine (Somily), King Saud University, King Saud University Medical City, Riyadh, Kingdom of Saudi Arabia.
King Saud Medical City · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo assess the antibacterial activity of ceftobiprole against Methicillin-resistant

methodsA retrospective cohort study with a total of 49 MRSA and 99

resultsApproximately 100% of the MRSA isolates were susceptible with MIC50/90 value of 1/1.5 mg/L while 69.8% of multi-drug resistant (MDR)

conclusionThe excellent activity of ceftobiprole against MRSA would have major implications in management of the patients with serious infections, as an empirical treatment or alternative to vancomycin. Ceftobiprole has a very low activity against MDR

Indexed as

Methicillin-Resistant Staphylococcus aureusPharmaceutical PreparationsStaphylococcal InfectionsAnti-Bacterial AgentsCephalosporinsHospitalsHumansMicrobial Sensitivity TestsPseudomonas aeruginosaRetrospective StudiesSaudi ArabiaTertiary Health CareAnti-Bacterial AgentsceftobiproleCephalosporinsPharmaceutical PreparationsceftobiproleMDR P. aeruginosaMRSAtertiary care

Identifiers

PMID35022281
PMCPMC9280555
OpenAlexW4206450346

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.